This article is from the source 'rtcom' and was first published or seen on . It last changed over 40 days ago and won't be checked again for changes.

You can find the current article at its original source at https://www.rt.com/usa/536802-moderna-forbes-400-list/

The article has changed 2 times. There is an RSS feed of changes available.

Version 0 Version 1
Trump out, Big Pharma in: Top Moderna executives make Forbes’ top 400 richest list Trump out, Big Pharma in: Top Moderna executives make Forbes’ top 400 richest list
(12 days later)
Three major figures at Big Pharma firm Moderna have made their way onto the prestigious Forbes 400 list, after raking in billions in Covid-19 vaccine sales to governments amid the global pandemic.Three major figures at Big Pharma firm Moderna have made their way onto the prestigious Forbes 400 list, after raking in billions in Covid-19 vaccine sales to governments amid the global pandemic.
Two founding members and a top investor at the company cracked into the catalogue of American affluence this week. The list charts the 400 richest citizens by net worth, and now includes Moderna’s chairman and co-founder, Noubar Afeyan, another co-founder, Robert Langer, as well as Timothy Springer, among the firm’s earliest investors. All three reportedly boast net worths of at least $3.5 billion each.Two founding members and a top investor at the company cracked into the catalogue of American affluence this week. The list charts the 400 richest citizens by net worth, and now includes Moderna’s chairman and co-founder, Noubar Afeyan, another co-founder, Robert Langer, as well as Timothy Springer, among the firm’s earliest investors. All three reportedly boast net worths of at least $3.5 billion each.
While all three remain far below the headliners on the 400 list – among them Jeff Bezos, Mark Zuckerberg, and Elon Musk – they were propelled onto the catalogue thanks to the massive global vaccination campaign against Covid-19, which has seen Moderna transact with governments around the world and pull in billions of dollars ultimately sourced from taxpayers. While all three remain far below the headliners on the 400 list – among them Jeff Bezos, Mark Zuckerberg, and Elon Musk – they were propelled onto the catalogue thanks to the massive global vaccination campaign against Covid-19, which has seen Moderna transact with governments around the world and pull in billions of dollars ultimately sourced from taxpayers. 
Springer ranked the highest out of the three, taking the 176th slot with a net worth of $5.9 billion. Ageyan followed, boasting $5 billion net in the 212th space, while Langer lagged just behind at $4.9 billion, placing 10 spaces lower at 222nd.Springer ranked the highest out of the three, taking the 176th slot with a net worth of $5.9 billion. Ageyan followed, boasting $5 billion net in the 212th space, while Langer lagged just behind at $4.9 billion, placing 10 spaces lower at 222nd.
The Moderna personnel cracked the list just as former US President Donald Trump lost his place this week, though the ex-president reportedly remains a billionaire.The Moderna personnel cracked the list just as former US President Donald Trump lost his place this week, though the ex-president reportedly remains a billionaire.
READ MORE: ‘Obscene to put profits before saving lives’: 9 new Big Pharma billionaires emerge amid Covid-19 vaccine rolloutREAD MORE: ‘Obscene to put profits before saving lives’: 9 new Big Pharma billionaires emerge amid Covid-19 vaccine rollout
However, the newfound opulence for the Moderna execs did not go over well for many observers online, some seeing a massive pharmaceutical corporation exploiting a health crisis to accrue obscene levels of wealth and use the world’s population as a captive market from which to bilk billions. Others also noted that large amounts of tax dollars went into developing components of the company’s vaccine.However, the newfound opulence for the Moderna execs did not go over well for many observers online, some seeing a massive pharmaceutical corporation exploiting a health crisis to accrue obscene levels of wealth and use the world’s population as a captive market from which to bilk billions. Others also noted that large amounts of tax dollars went into developing components of the company’s vaccine.
“The US government paid for the development of Moderna's Covid vaccine to the tune of $1.4 billion & then the US gov't bought Moderna's vaccines to give to us,” tweeted Nature reporter Amy Maxmen, adding sardonically: “Congrats to Moderna's founders for making Forbes billionaires list!”“The US government paid for the development of Moderna's Covid vaccine to the tune of $1.4 billion & then the US gov't bought Moderna's vaccines to give to us,” tweeted Nature reporter Amy Maxmen, adding sardonically: “Congrats to Moderna's founders for making Forbes billionaires list!”
Some detractors also noted Moderna’s reluctance to waive its intellectual property rights to its Covid-19 vaccine – a move repeatedly endorsed by the World Health Organization (WHO), arguing it could help accelerate vaccine production worldwide. A host of Big Pharma firms have vocally opposed the profit-killing idea, however, and while the Biden administration has signaled some support for it in concept, it has done little to make an IP waiver a reality.Some detractors also noted Moderna’s reluctance to waive its intellectual property rights to its Covid-19 vaccine – a move repeatedly endorsed by the World Health Organization (WHO), arguing it could help accelerate vaccine production worldwide. A host of Big Pharma firms have vocally opposed the profit-killing idea, however, and while the Biden administration has signaled some support for it in concept, it has done little to make an IP waiver a reality.
Think your friends would be interested? Share this story!Think your friends would be interested? Share this story!
Dear readers and commenters,
We have implemented a new engine for our comment section. We hope the transition goes smoothly for all of you. Unfortunately, the comments made before the change have been lost due to a technical problem. We are working on restoring them, and hoping to see you fill up the comment section with new ones. You should still be able to log in to comment using your social-media profiles, but if you signed up under an RT profile before, you are invited to create a new profile with the new commenting system.
Sorry for the inconvenience, and looking forward to your future comments,
RT Team.